Transuretral resection of the bladder (TURB): Analysis of complications using a modified Clavien system in an Italian real life cohort
Transuretral resection of the bladder (TURB): Analysis of complications using a modified Clavien system in an Italian real life cohort
复制标题
DOI:
10.1016/j.ejso.2013.11.003
复制
发表时间:
2014-01-01
期刊:
影响因子:
3.8
通讯作者:
Tubaro, A.
中科院分区:
文献类型:
--
作者:
De Nunzio, C.;Franco, G.;Tubaro, A.
Introduction: To evaluate the applicability of a modified Clavien classification system (CCS) in grading postoperative complications of transurethral resection of bladder tumours (TURB).Materials and methods: A series of patients undergoing monopolar TURB from April 2011 to March 2012 at five Italian centers were enrolled. All complications occurring within the first 30-day postoperative period were prospectively recorded and graded according to the CCS.Results: Overall, 275 patients were included. Median age was 71(63/78) years; median BMI was 28 (25.4/30.8) Kg/m(2), median tumour size was 2 (1-3) cm; median number of tumour lesions was 1 (1-3). Median operative time was 30 (20/45) min. Fifty-seven complications. were recorded in 43 patients. Overall postoperative morbidity rate was 16%. Most of the complications were not serious and classified as Clavien type I (42 cases; 74%) or II (8 cases, 14%). Higher grade complications were scarce: CCS IIIa in 1 case (2%) and CCS IIIb in six cases (10%). No TURB related death was reported. Six patients were re-operated due to significant bleeding or clot retention on postoperative days 2-7. On univariate (73.5 +/- 38 versus 36.7 +/- 21.6 min) and multivariate analysis longer operative time was an independent predictor of complications (OR: 1.06 per mm, 95%CI 1.04-1.08, p = 0.001).Conclusions: A modified CCS can be used as a standardized tool to objectively define the complications of TURB which confirms to be a safe procedure with a low surgical morbidity. This tool can be used to aid in patient counselling and to facilitate scientific assessment. (C) 2013 Elsevier Ltd. All rights reserved.